NCT04759846 2023-02-21Hepatic Impairment Study of Encorafenib in Combination With Binimetinib in BRAF MelanomaPierre Fabre MedicamentPhase 1 Withdrawn
NCT02451865 2020-07-24Binimetinib With Docetaxel in Treating Patients With Previously Treated, Stage IV Non-small Cell Lung CancerJonsson Comprehensive Cancer CenterPhase 1 Withdrawn